Cargando…
Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19
Cytokine release syndrome is prevalent in severe cases of COVID-19. In this syndrome, an uncontrolled response of immune system occurs. Extracorporeal blood purification has been proven to effectively remove the released inflammatory cytokines. Here, we reported a successful case to represent our ex...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185011/ https://www.ncbi.nlm.nih.gov/pubmed/32353526 http://dx.doi.org/10.1016/j.jgar.2020.04.024 |
_version_ | 1783526684910157824 |
---|---|
author | Dastan, Farzaneh Saffaei, Ali Mortazavi, Seyed Mehdi Jamaati, Hamidreza Adnani, Nadia Samiee Roudi, Sasan Kiani, Arda Abedini, Atefeh Hashemian, Seyed MohammadReza |
author_facet | Dastan, Farzaneh Saffaei, Ali Mortazavi, Seyed Mehdi Jamaati, Hamidreza Adnani, Nadia Samiee Roudi, Sasan Kiani, Arda Abedini, Atefeh Hashemian, Seyed MohammadReza |
author_sort | Dastan, Farzaneh |
collection | PubMed |
description | Cytokine release syndrome is prevalent in severe cases of COVID-19. In this syndrome, an uncontrolled response of immune system occurs. Extracorporeal blood purification has been proven to effectively remove the released inflammatory cytokines. Here, we reported a successful case to represent our experience of extracorporeal blood purification in a patient with severe COVID-19. |
format | Online Article Text |
id | pubmed-7185011 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71850112020-04-27 Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19 Dastan, Farzaneh Saffaei, Ali Mortazavi, Seyed Mehdi Jamaati, Hamidreza Adnani, Nadia Samiee Roudi, Sasan Kiani, Arda Abedini, Atefeh Hashemian, Seyed MohammadReza J Glob Antimicrob Resist Short Communication Cytokine release syndrome is prevalent in severe cases of COVID-19. In this syndrome, an uncontrolled response of immune system occurs. Extracorporeal blood purification has been proven to effectively remove the released inflammatory cytokines. Here, we reported a successful case to represent our experience of extracorporeal blood purification in a patient with severe COVID-19. The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. 2020-06 2020-04-27 /pmc/articles/PMC7185011/ /pubmed/32353526 http://dx.doi.org/10.1016/j.jgar.2020.04.024 Text en © 2020 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Dastan, Farzaneh Saffaei, Ali Mortazavi, Seyed Mehdi Jamaati, Hamidreza Adnani, Nadia Samiee Roudi, Sasan Kiani, Arda Abedini, Atefeh Hashemian, Seyed MohammadReza Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19 |
title | Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19 |
title_full | Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19 |
title_fullStr | Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19 |
title_full_unstemmed | Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19 |
title_short | Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19 |
title_sort | continues renal replacement therapy (crrt) with disposable hemoperfusion cartridge: a promising option for severe covid-19 |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185011/ https://www.ncbi.nlm.nih.gov/pubmed/32353526 http://dx.doi.org/10.1016/j.jgar.2020.04.024 |
work_keys_str_mv | AT dastanfarzaneh continuesrenalreplacementtherapycrrtwithdisposablehemoperfusioncartridgeapromisingoptionforseverecovid19 AT saffaeiali continuesrenalreplacementtherapycrrtwithdisposablehemoperfusioncartridgeapromisingoptionforseverecovid19 AT mortazaviseyedmehdi continuesrenalreplacementtherapycrrtwithdisposablehemoperfusioncartridgeapromisingoptionforseverecovid19 AT jamaatihamidreza continuesrenalreplacementtherapycrrtwithdisposablehemoperfusioncartridgeapromisingoptionforseverecovid19 AT adnaninadia continuesrenalreplacementtherapycrrtwithdisposablehemoperfusioncartridgeapromisingoptionforseverecovid19 AT samieeroudisasan continuesrenalreplacementtherapycrrtwithdisposablehemoperfusioncartridgeapromisingoptionforseverecovid19 AT kianiarda continuesrenalreplacementtherapycrrtwithdisposablehemoperfusioncartridgeapromisingoptionforseverecovid19 AT abediniatefeh continuesrenalreplacementtherapycrrtwithdisposablehemoperfusioncartridgeapromisingoptionforseverecovid19 AT hashemianseyedmohammadreza continuesrenalreplacementtherapycrrtwithdisposablehemoperfusioncartridgeapromisingoptionforseverecovid19 |